QAU · Class II · 21 CFR 878.4456

FDA Product Code QAU: Hemostatic Device For Endoscopic Gastrointestinal Use

Hemostatic Device For Intraluminal Gastrointestinal Use. A Hemostatic Device For Intraluminal Gastrointestinal Use Is A Prescription Device That Is Endoscopically Applied To The Upper And/or Lower Gastrointestinal Tract And Is Intended To Produce Hemostasis Via Absorption Of Fluid Or By Other Physical Means.

Leading manufacturers include 3-D Matrix Europe SAS, Hemostasis, LLC and Nextbiomedical Co., Ltd..

10
Total
9
Cleared
280d
Avg days
2018
Since
Growing category - 4 submissions in the last 2 years vs 2 in the prior period
Review times improving: avg 139d recently vs 374d historically

FDA 510(k) Cleared Hemostatic Device For Endoscopic Gastrointestinal Use Devices (Product Code QAU)

10 devices
1–10 of 10

About Product Code QAU - Regulatory Context

510(k) Submission Activity

10 total 510(k) submissions under product code QAU since 2018, with 9 receiving FDA clearance (average review time: 280 days).

Submission volume has increased in recent years - 4 submissions in the last 24 months compared to 2 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under QAU have taken an average of 139 days to reach a decision - down from 374 days historically, suggesting improved FDA processing for this classification.

QAU devices are reviewed by the General & Plastic Surgery panel. Browse all General & Plastic Surgery devices →